Towards consensus in the long-term management of relapse prevention in schizophrenia
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
APPROACH TO DEVELOPING GUIDANCE: When developing guidance for the long-term management of schizophrenia, one approach is to adopt a proactive strategy that sets out clear treatment goals and strategies. This should involve a broad view being taken, embracing overall mental and physical well-being rather than simply the absence of illness. Although relapse prevention is an important goal of any long-term management strategy, there are other aspects that need to be considered, such as reintegration into society, regaining independence and quality of life. CURRENT TREATMENT: To help achieve these goals, a range of interventions can be incorporated into long-term management strategies for schizophrenia, including pharmacological interventions, psychosocial therapies and alliance-building initiatives. The current UK National Institute for Clinical Excellence guidelines already recommend that continuous therapy should be practised using an atypical (second-generation) antipsychotic drug, whenever possible, in preference to older typical drugs. The launch of the first long-acting atypical antipsychotic is an interesting new advance that may benefit many patients with schizophrenia. Psychosocial interventions, particularly family-based therapies, as well as cognitive behavioural and compliance therapies, when used alongside antipsychotics, have been shown to reduce relapse rates dramatically and to assist in social reintegration. In addition, forging collaborative alliances with patients and their carers can help to demystify schizophrenia and empower patients to take responsibility for their illness. CONSENSUS STATEMENT: This article outlines a consensus reached by a panel of leading UK healthcare professionals working with schizophrenia brought together to discuss long-term management strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J. E., Day, R., & Bertelsen, A. (1992) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000904 · Cited by 1,769
Expressed Emotion and Psychiatric Relapse: A Meta-analysis
Butzlaff, R. L., & Hooley, J. M. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.6.547 · Cited by 1,310 · cited 1×
“It is known that stressful life events and increased emotional state can both trigger relapse and increase relapse rates (Butzlaff and Hooley, 1998; Nuechterlein et al., 1994).”
BackgroundCsernansky, J. G., Mahmoud, R., & Brenner, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa002028 · Cited by 605 · cited 2×
“Atypicals such as risperidone, olanzapine, amisulpride and quetiapine are highly effective in treating acute psychotic symptoms (Conley et al., 1999; Leucht et al., 1999; Leucht et al., 2003) and also have efficacy with regard to negative and affective symptoms (Csernansky et al., 2002).”
BackgroundThe vulnerability/stress model of schizophrenic relapse: a longitudinal study
Nuechterlein, K. H., Dawson, M. E., Ventura, J., Gitlin, M., Subotnik, K. L., Snyder, K. S., Mintz, J., & Bartzokis, G. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb05867.x · Cited by 196 · cited 1×
“It is known that stressful life events and increased emotional state can both trigger relapse and increase relapse rates (Butzlaff and Hooley, 1998; Nuechterlein et al., 1994).”
BackgroundCompliance with antipsychotic treatment
Oehl, M., Hummer, M., & Fleischhacker, W. W. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.00016.x · Cited by 151 · cited 1×
“…the inefficacy and poor tolerability of typical antipsychotic medication can be responsible for relapse (Gerlach, 2002; Tattan and Creed, 2001), as can non-concordance with treatment, which can be particularly difficult to assess and follow up in patients with schizophrenia (Oehl et al., 2000).”
Background
Cited by
Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review
Olivares, J. M., Sermon, J., Hemels, M., & Schreiner, A. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-32 · Cited by 270
“[7,27,29,34,38,43,63,67,75-81]; deliberate self-harm or violent behaviour, suicidal or homicidal ideation, arrest [18,23,27,43,49,50,57,65,66,71,74,82-84];”
BackgroundMethodInfluentialPatrick, D. L., Burns, T., Morosini, P., Gagnon, D. D., Rothman, M., & Adriaenssen, I. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.02.003 · Cited by 32
Correlates of rehospitalisation in schizophrenia
Dey, S., Menkes, D. B., Obertova, Z., Chaudhuri, S., & Mellsop, G. (2016) · Australasian Psychiatry · doi:10.1177/1039856216632395 · Cited by 9
Metadata
- Authors
- Taylor, M., Chaudhry, I., Cross, M., McDonald, E., Miller, P., Pilowsky, L., Strickland, P., & Relapse Prevention in Schizophrenia Consensus Group
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2005
- Volume
- 20
- Issue
- 3
- Pages
- 175-181
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W2014707913
- Cited by
- 67
- References
- 5
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.